Severity
Moderate
FDA Drug recall · Reported June 24, 2015
CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints.
Allegiant Health recalled Famotidine Tablets, USP, 20 mg Tablets, Over the Counter, Made in India and labeled: a) f… - a moderate-severity action.
Famotidine Tablets, USP, 20 mg Tablets, Over the Counter, Made in India and labeled: a) f… was recalled by Allegiant Health in June 24, 2015. Reason: CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints.. Check the official notice for the remedy. Verify recall #D-1134-2015 with the FDA Drug before acting.
The recall
Allegiant Health issued this moderate-severity FDA Drug recall-CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints..
Sourced from official FDA Drug enforcement records. Verify recall #D-1134-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1134-2015) was formally reported on June 24, 2015, with the manufacturer initiating the action on May 12, 2015. It is classified under Moderate severity (Class II), with a current status of Terminated. Allegiant Health is listed as the recalling firm, operating out of Deer Park, NY. Federal records list the affected scope as 86,106 Cartons.
The documented reason for this recall is: CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints. Distribution data in the federal record shows the product reached: US Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
86,106 Cartons
Related Recalls
6
5 from same agency
Famotidine Tablets, USP, 20 mg Tablets, Over the Counter, Made in India and labeled: a) freds Acid Controller, 25 Tablet Cartons, DISTRIBUTED BY: fred's, Inc. 4300 NEW GETWELL RD, MEMPHIS, TN 38118. UPC: 0 84579 12592 0. b) HARMON FACE VALUES MAXIMUM STRENGTH Heartburn RELIEF, 25 Tablet Cartons, Distributed by Harmon Stores, Inc. 650 Liberty Ave. Union, NJ 07083, UPC: 3 62211 93292 2. c) Health A2Z Maximum Strength HEARTBURN RELIEF, 8 Tablet Cartons, Manufactured for: A&Z Pharmaceutical Inc. Hauppauge, NY 11788. UPC: 3 62211 34929 4. d) MARKET BASKET Maximum Strength HEARTBURN RELIEF ACID CONTROL, 30 Tablet Cartons, Distributed by: Demoulas Supermarkets, Inc. 875 East St. Tewksbury, MA 01876, UPC: 0 49705 83147 2.
CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1134-2015 |
| Date reported | June 24, 2015 |
| Date initiated | May 12, 2015 |
| Recalling firm | Allegiant Health |
| Firm location | Deer Park, NY |
| Affected scope | 86,106 Cartons |
| Distribution | US Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported June 24, 2015. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.